Simplex Trading
LFCR icon

Simplex Trading’s Lifecore Biomedical LFCR Stock Holding History

Simplex Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.4K Buy
6,277
+4,949
+373% +$34.2K ﹤0.01% 6646
2025
Q4 		$10.9K Sell
1,328
-2,069
-61% -$15.3K ﹤0.01% 6934
2025
Q3 		$25K Buy
+3,397
New +$25.7K ﹤0.01% 7139
2024
Q4 		– Sell
-5,071
Closed -$32.4K – 9134
2024
Q3 		$25K Buy
5,071
+708
+16% +$3.7K ﹤0.01% 6501
2024
Q2 		$22K Buy
4,363
+1,250
+40% +$7.4K ﹤0.01% 6807
2024
Q1 		$16K Sell
3,113
-1,542
-33% -$11K ﹤0.01% 7270
2023
Q4 		$28K Sell
4,655
-60,053
-93% -$417K ﹤0.01% 6629
2023
Q3 		$488K Buy
64,708
+9,434
+17% +$86.2K ﹤0.01% 3426
2023
Q2 		$534K Buy
55,274
+5,873
+12% +$35.9K ﹤0.01% 3241
2023
Q1 		$186K Buy
49,401
+38,527
+354% +$215K ﹤0.01% 4413
2022
Q4 		$70K Buy
10,874
+8,440
+347% +$69.6K ﹤0.01% 5473
2022
Q3 		$21K Sell
2,434
-1,586
-39% -$16.1K ﹤0.01% 7467
2022
Q2 		$40K Buy
4,020
+3,109
+341% +$30.8K ﹤0.01% 6769
2022
Q1 		$10K Buy
911
+879
+2,747% +$9.79K ﹤0.01% 8870
2021
Q4 		$0 Sell
32
-387
-92% -$3.76K ﹤0.01% 10971
2021
Q3 		$4K Sell
419
-200
-32% -$2.18K ﹤0.01% 9350
2021
Q2 		$6K Buy
+619
New +$7.13K ﹤0.01% 9379
2021
Q1 		– Sell
-97
Closed -$1.09K – 9449
2020
Q4 		$1K Sell
97
-3,949
-98% -$40.8K ﹤0.01% 8121
2020
Q3 		$39K Buy
4,046
+3,568
+746% +$34K ﹤0.01% 5842
2020
Q2 		$3K Buy
+478
New +$4.93K ﹤0.01% 7155
2019
Q2 		– Sell
-300
Closed -$3K – 7473
2019
Q1 		$3K Sell
300
-140
-32% -$1.71K ﹤0.01% 6665
2018
Q4 		$5K Buy
440
+205
+87% +$2.81K ﹤0.01% 6213
2018
Q3 		$3K Buy
+235
New +$3.25K ﹤0.01% 6966
2018
Q2 		– Sell
-23,176
Closed -$302K – 7648
2018
Q1 		$302K Buy
23,176
+23,020
+14,756% +$302K 0.01% 985
2017
Q4 		$1K Buy
+156
New +$1.97K ﹤0.01% 5551
2017
Q1 		– Sell
-394
Closed -$5K – 6472
2016
Q4 		$5K Buy
+394
New +$5.46K ﹤0.01% 4353

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's LFCR Position: Q1 2026 in Review

Simplex Trading increased its Lifecore Biomedical (LFCR) stake by 373% in Q1 2026, buying an estimated $34.2K and bringing the position to 6,277 shares worth $23.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6646.

Simplex Trading first reported a position in LFCR in Q4 2016 and has held it in 26 quarters since. The position peaked at $534K in Q2 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Simplex Trading held 6,277 shares of Lifecore Biomedical worth $23.4K as of Q1 2026.
  • Simplex Trading bought 4,949 Lifecore Biomedical shares in Q1 2026, an estimated $34.2K.
  • Lifecore Biomedical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6646 holding.
  • Simplex Trading first reported a position in Lifecore Biomedical in Q4 2016 and has held it in 26 quarters since.
  • Simplex Trading's Lifecore Biomedical position peaked at $534K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.